At the news
? BEARISHIMPACT 6/10 424B5 filed Jun 9, 2026 at 17:16 ET
IDEAYA Biosciences is raising approximately $281.3 million in net proceeds through a public offering of 5,555,556 shares of common stock and pre-funded warrants to purchase 5,555,576 shares, priced at $27.00 per share (and $26.9999 per pre-funded warrant). The offering represents roughly 6.3% dilution to existing shareholders based on shares outstanding as of March 31, 2026, and was priced at a 14.2% discount to the last closing price of $31.48. Proceeds will fund continued clinical development and potential commercialization of darovasertib for uveal melanoma, pipeline advancement, and general corporate purposes.
- Offering of 5,555,556 shares of common stock and pre-funded warrants to purchase 5,555,576 shares at $27.00 per share/$26.9999 per warrant
- Net proceeds of approximately $281.3 million ($323.6 million if underwriters' option exercised in full)
- Priced at a 14.2% discount to the $31.48 closing price on June 8, 2026
- Immediate dilution of $13.95 per share to new investors; as-adjusted net tangible book value increases from $10.67 to $13.05 per share
Before · The news · First close · A day later · A week later
Replay the market's reaction
Step through every 5 minutes around the news, then see how it compares with similar events.
Subscribe for Full Access